Lncrna Meg3 Mediates Nickel Oxide Nanoparticles-Induced Pulmonary Fibrosis Via Suppressing Tgf-Beta 1 Expression And Epithelial-Mesenchymal Transition Process

Haibing Zhan,Xuhong Chang,Xiaoxia Wang,Mengmeng Yang,Qing Gao,Han Liu,Chengyun Li,Sheng Li,Yingbiao Sun
DOI: https://doi.org/10.1002/tox.23109
IF: 4.109
2021-01-01
Environmental Toxicology
Abstract:Nickel oxide nanoparticles (NiO NPs) causes pulmonary fibrosis via activating transforming growth factor-beta 1 (TGF-beta 1) in rats, but its upstream regulatory mechanisms are unknown. This study aimed to explore the role of long noncoding RNA (lncRNA) maternally expressed gene 3 (MEG3) in NiO NPs-induced collagen deposition. Male Wistar rats were intratracheally instilled with NiO NPs (0.015, 0.06, and 0.24 mg/kg b.w.) twice a week for 9 weeks. Human lung adenocarcinoma epithelial cells (A549 cells) were cultured with NiO NPs (25, 50, and 100 mu g/ml) to establish collagen deposition model. We discovered that NiO NPs-induced rat pulmonary fibrosis was accompanied by the epithelial-mesenchymal transition (EMT) occurrence and MEG3 down-regulation in rat lung tissues. In cell collagen deposition model, NiO NPs also evoked EMT and decreased MEG3 expression in a dose-dependent manner in A549 cells. By overexpressing MEG3 in A549 cells, we found that MEG3 inhibited the level of TGF-beta 1, EMT process and collagen formation. Moreover, our data showed that SB431542 (TGF-beta 1 inhibitor) had an inhibitory effect on NiO NPs-induced EMT and collagen formation. Our results indicated that MEG3 inhibited NiO NPs-induced collagen deposition by regulating TGF-beta 1-mediated EMT process, which may provide some clues for insighting into the mechanisms of NiO NPs-induced pulmonary fibrosis.
What problem does this paper attempt to address?